<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7296524\results\search\disease\results.xml">
  <result pre=": Review Consensus statement of the Italian society of pediatric" exact="allergy" post="and immunology for the pragmatic management of children and"/>
  <result pre="[10], grid.9841.40000 0001 2200 8888Department of Woman and Child and" exact="General" post="and Specialized Surgery, University of Campania Luigi Vanvitelli, [11],"/>
  <result pre="of care. Mortality has been associated with severe comorbidities, including" exact="chronic" post="diseases. Patients with frailty were, therefore, the victim of"/>
  <result pre="were, therefore, the victim of the SARS-COV-2 infection. Allergy and" exact="asthma" post="are the most prevalent chronic disorders in children and"/>
  <result pre="the SARS-COV-2 infection. Allergy and asthma are the most prevalent" exact="chronic" post="disorders in children and adolescents, so they need careful"/>
  <result pre="the pandemic. Based on this background, the Italian Society of" exact="Pediatric" post="Allergy and Immunology has felt it necessary to provide"/>
  <result pre="allergic or immunologic diseases. Keywords COVID-19 Pandemic Child Adolescent Allergy" exact="Asthma" post="Immunologic disease Introduction A novel coronavirus, SARS-COV-2, lead to"/>
  <result pre="or immunologic diseases. Keywords COVID-19 Pandemic Child Adolescent Allergy Asthma" exact="Immunologic" post="disease Introduction A novel coronavirus, SARS-COV-2, lead to coronavirus"/>
  <result pre="immunologic diseases. Keywords COVID-19 Pandemic Child Adolescent Allergy Asthma Immunologic" exact="disease" post="Introduction A novel coronavirus, SARS-COV-2, lead to coronavirus disease"/>
  <result pre="Immunologic disease Introduction A novel coronavirus, SARS-COV-2, lead to coronavirus" exact="disease" post="2019 (COVID-19). COVID-19 burst in China and rapidly spread"/>
  <result pre="In particular, it has been reported that severe and lethal" exact="disease" post="is associated with male gender, old age, and comorbidity."/>
  <result pre="is associated with male gender, old age, and comorbidity. Fortunately," exact="childhood" post="seems to be preserved by severe COVID-19, and relatively"/>
  <result pre="still now. Every age may be affected, including infancy. As" exact="chronic" post="diseases have been associated with more severe COVID-19, the"/>
  <result pre="emerged. Therefore, the executive board of the Italian Society of" exact="Pediatric" post="Allergy and Immunology (SIAIP) has considered appropriate to disseminate"/>
  <result pre="document including a series of recommendations for the management of" exact="allergies" post="and immunological diseases in children and adolescents. All SIAP"/>
  <result pre="The recommendations are mainly based on principles as very few" exact="primary" post="data are available at present. Allergic rhinitis In the"/>
  <result pre="principles as very few primary data are available at present." exact="Allergic" post="rhinitis In the current state of knowledge, topical nasal"/>
  <result pre="as very few primary data are available at present. Allergic" exact="rhinitis" post="In the current state of knowledge, topical nasal corticosteroid"/>
  <result pre="the current state of knowledge, topical nasal corticosteroid therapy for" exact="allergic rhinitis" post="in children and adolescents with COVID-19 can be continued"/>
  <result pre="current state of knowledge, topical nasal corticosteroid therapy for allergic" exact="rhinitis" post="in children and adolescents with COVID-19 can be continued"/>
  <result pre="indeed the non-administration may lead to an increase in nasal" exact="respiratory" post="symptoms, in particular, nasal obstruction with a more probable"/>
  <result pre="of potentially infected secretions and with a higher risk of" exact="bacterial" post="colonization also of the lower airways. It should also"/>
  <result pre="with a higher risk of bacterial colonization also of the" exact="lower" post="airways. It should also be remembered that the increase"/>
  <result pre="airways. It should also be remembered that the increase in" exact="rhinitis" post="symptoms with frequent sneezing leads to a higher potential"/>
  <result pre="virus. Moreover, as itching is a typical symptom of both" exact="allergic rhinitis" post="and conjunctivitis, appropriate management of this symptom should be"/>
  <result pre="Moreover, as itching is a typical symptom of both allergic" exact="rhinitis" post="and conjunctivitis, appropriate management of this symptom should be"/>
  <result pre="Second-generation antihistamines should be, therefore, used to control nasal and" exact="ocular" post="itching. Effective and safe oral medications should be preferred,"/>
  <result pre="such as cetirizine, loratadine, and fexofenadine, to relieve nasal and" exact="ocular" post="complaints [3â€&quot;5]. These recommendations have to be updated regularly"/>
  <result pre="updated regularly in light of the continuous acquisitions on COVID-19." exact="Asthma" post="Continue to administer medications prescribed to maintain asthma control"/>
  <result pre="on COVID-19. Asthma Continue to administer medications prescribed to maintain" exact="asthma" post="control regularly, in particular, inhaled corticosteroids (ICS), long-acting bronchodilators,"/>
  <result pre="the child or adolescent to the risk of even severe" exact="asthma" post="exacerbations. For patients with severe asthma, it is advisable"/>
  <result pre="only exception could be the suspension of biologics during the" exact="acute" post="phase of COVID-19 infection. Patients with asthma (particularly severe"/>
  <result pre="biologics during the acute phase of COVID-19 infection. Patients with" exact="asthma" post="(particularly severe or uncontrolled asthma) are at increased risk"/>
  <result pre="phase of COVID-19 infection. Patients with asthma (particularly severe or" exact="uncontrolled" post="asthma) are at increased risk of developing more severe"/>
  <result pre="at increased risk of developing more severe COVID-19 [5â€&quot;8]. Preexisting" exact="allergies" post="have not been classified as a risk factor. However,"/>
  <result pre="allergies have not been classified as a risk factor. However," exact="Pediatric" post="allergists must obtain the best control of asthma and"/>
  <result pre="factor. However, Pediatric allergists must obtain the best control of" exact="asthma" post="and the allergic condition and educate patients and their"/>
  <result pre="current recommendations to reduce the risk of COVID-19. In particular," exact="uncontrolled" post="asthma is the most crucial risk factor for severe"/>
  <result pre="recommendations to reduce the risk of COVID-19. In particular, uncontrolled" exact="asthma" post="is the most crucial risk factor for severe COVID-19"/>
  <result pre="medical Emergency helpline or go to the Emergency Room for" exact="acute" post="worsening of asthma. Always prescribe asthma medications in more"/>
  <result pre="the Emergency Room for acute worsening of asthma. Always prescribe" exact="asthma" post="medications in more significant quantities to make up for"/>
  <result pre="of supplies. It is crucial for the clinicians, in the" exact="asthma" post="management, to communicate the asthma action plan to patients"/>
  <result pre="for the clinicians, in the asthma management, to communicate the" exact="asthma" post="action plan to patients and their parents, to obtain"/>
  <result pre="and the â€œpatient engagementâ€� in the regular treatment and the" exact="asthma" post="exacerbations [2, 6â€&quot;9]. Avoid spirometry in patients with confirmed/suspected"/>
  <result pre="asthma exacerbations [2, 6â€&quot;9]. Avoid spirometry in patients with confirmed/suspected" exact="infection" post="by COVID-19, since the execution of this test can"/>
  <result pre="other patients to the risk of infection. Therefore, postpone the" exact="respiratory" post="function tests or perform them only in case of"/>
  <result pre="wearing PPE, as part of the health activity and rigorous" exact="infection" post="control procedures if aerosol generation procedures are required (for"/>
  <result pre="social distancing and preventive rules, especially when evaluating patients with" exact="respiratory" post="symptoms, always ensuring cleanliness and hygiene of the sanitary"/>
  <result pre="in the expression of ACE2 receptors, present mainly in the" exact="lower" post="respiratory tract [10â€&quot;13]. ACE2 is the coronavirus receptor: through"/>
  <result pre="the expression of ACE2 receptors, present mainly in the lower" exact="respiratory" post="tract [10â€&quot;13]. ACE2 is the coronavirus receptor: through binding"/>
  <result pre="the coronavirus receptor: through binding with it, coronavirus penetrates the" exact="pulmonary" post="alveolus and thus infects the individual. Therefore, an increased"/>
  <result pre="an increased expression of ACE2, induced by smoking, means increased" exact="susceptibility to" post="contract the COVID-19 infection and potentially to develop a"/>
  <result pre="induced by smoking, means increased susceptibility to contract the COVID-19" exact="infection" post="and potentially to develop a more severe form. Food"/>
  <result pre="infection and potentially to develop a more severe form. Food" exact="allergy" post="Consider the choice of â€œsafeâ€� food as a priority."/>
  <result pre="adrenaline) and two available adrenaline auto-injectors. In children with food" exact="allergies" post="(FA), the avoidance of the culprit food currently represents"/>
  <result pre="(FA), the avoidance of the culprit food currently represents the" exact="primary" post="treatment. The choice of â€œsafeâ€� food is crucial for"/>
  <result pre="advent of the pandemic, people may have difficulty accessing specialist" exact="allergy" post="products, because of high demand in shops or low"/>
  <result pre="and two available adrenaline auto-injectors. The child/adolescent suffering from food" exact="allergies" post="must consume a well-balanced and varied diet, also rich"/>
  <result pre="children with food allergies, the exclusion diet is currently the" exact="primary" post="treatment. Depending on the age of the child and"/>
  <result pre="intake, especially in preschoolers. The diet should be varied and" exact="complete" post="to assure the right intake of macro and micronutrients."/>
  <result pre="by suspected FA, except for those with cowâ€™s milk protein" exact="allergy" post="who do not have a milk substitute or comorbidities,"/>
  <result pre="tolerating the substitutive milk or is highly suspected of an" exact="allergy" post="misdiagnosis resulting in an unnecessary elimination diet. In other"/>
  <result pre="FA), OFC should be re-scheduled. In the case of uncertain" exact="symptomatic" post="ingestion, the reintroducing of food may be delayed, and"/>
  <result pre="Control visits at the office should be postponed unless severe" exact="systemic" post="reactions suggesting a new food allergy is reported. Any"/>
  <result pre="should be postponed unless severe systemic reactions suggesting a new" exact="food allergy" post="is reported. Any new patient visit for an elimination"/>
  <result pre="be postponed unless severe systemic reactions suggesting a new food" exact="allergy" post="is reported. Any new patient visit for an elimination"/>
  <result pre="trial may be delayed unless an IgE-mediated reaction, FPIES, or" exact="eosinophilic esophagitis" post="are suspected. Priority should be given to patients suffering"/>
  <result pre="may be delayed unless an IgE-mediated reaction, FPIES, or eosinophilic" exact="esophagitis" post="are suspected. Priority should be given to patients suffering"/>
  <result pre="are suspected. Priority should be given to patients suffering from" exact="recurrent" post="idiopathic anaphylaxis. In children with FA, initiation of oral"/>
  <result pre="until new medical indications. Patients affected by some kind of" exact="food allergy" post="(e.g., peanut allergy) may benefit from oral immunotherapy (OIT)"/>
  <result pre="new medical indications. Patients affected by some kind of food" exact="allergy" post="(e.g., peanut allergy) may benefit from oral immunotherapy (OIT)"/>
  <result pre="under medical supervision because of the risk of potentially severe" exact="systemic" post="reactions. Therefore, the initiation of OIT should be postponed."/>
  <result pre="of allergen at home until new medical indications are given." exact="Atopic dermatitis" post="The presence of atopic dermatitis requires special precautions for"/>
  <result pre="allergen at home until new medical indications are given. Atopic" exact="dermatitis" post="The presence of atopic dermatitis requires special precautions for"/>
  <result pre="new medical indications are given. Atopic dermatitis The presence of" exact="atopic dermatitis" post="requires special precautions for the application of the necessary"/>
  <result pre="medical indications are given. Atopic dermatitis The presence of atopic" exact="dermatitis" post="requires special precautions for the application of the necessary"/>
  <result pre="allergic contact phenomena. To minimize this risk, subjects suffering from" exact="atopic dermatitis" post="should prefer to wash their hands with soap and"/>
  <result pre="contact phenomena. To minimize this risk, subjects suffering from atopic" exact="dermatitis" post="should prefer to wash their hands with soap and"/>
  <result pre="and water rather than with antiseptic agents (i.e., chlorhexidine) or" exact="alcoholic" post="sanitizer, avoid excessive washing or with too hot water,"/>
  <result pre="the family doctor for further therapies [19â€&quot;23]. The presence of" exact="atopic dermatitis" post="or active skin lesions has not been associated with"/>
  <result pre="family doctor for further therapies [19â€&quot;23]. The presence of atopic" exact="dermatitis" post="or active skin lesions has not been associated with"/>
  <result pre="a higher risk of contracting SARS-CoV-2 infection. AD is a" exact="syndrome" post="characterized by immune dysregulation, but there is no evidence"/>
  <result pre="is not currently known whether the transmission of the SARS-CoV-2" exact="infection" post="is more likely to occur in subjects with active"/>
  <result pre="exuding skin lesions. However, as coronavirus appears to spread through" exact="respiratory" post="droplets, it appears highly unlikely that a damaged skin"/>
  <result pre="barrier increases the risk of developing COVID-19. Patients suffering from" exact="atopic dermatitis" post="who are taking an immunosuppressant drug/biological drug/oral steroids must"/>
  <result pre="increases the risk of developing COVID-19. Patients suffering from atopic" exact="dermatitis" post="who are taking an immunosuppressant drug/biological drug/oral steroids must"/>
  <result pre="be adopted during the current COVID-19 pandemic for patients with" exact="skin diseases," post="including eczema, who carry out immunomodulatory therapies [26]. There"/>
  <result pre="for whom COVID-19 poses a higher risk due to their" exact="disease" post="and treatment. Interruption of drug therapy should only be"/>
  <result pre="physician, who decide on an individual basis [29]. Drug and" exact="latex allergy" post="It is recommended to delay the workup for suspected"/>
  <result pre="who decide on an individual basis [29]. Drug and latex" exact="allergy" post="It is recommended to delay the workup for suspected"/>
  <result pre="allergy It is recommended to delay the workup for suspected" exact="drug hypersensitivity" post="if there is a well-tolerated drug with the same"/>
  <result pre="It is recommended to delay the workup for suspected drug" exact="hypersensitivity" post="if there is a well-tolerated drug with the same"/>
  <result pre="that could be necessary to investigate in children for presumed" exact="hypersensitivity" post="includes more common antibiotics and antipyretics, but also chemotherapeutics,"/>
  <result pre="suspected drug, which has been tolerated from the patient, the" exact="drug hypersensitivity" post="workup could be delayed. The drug challenge should be"/>
  <result pre="drug, which has been tolerated from the patient, the drug" exact="hypersensitivity" post="workup could be delayed. The drug challenge should be"/>
  <result pre="potential treatments for COVID-19 infection. In the case of suspected" exact="hypersensitivity" post="to these drugs, patients should undergo a complete allergy"/>
  <result pre="of suspected hypersensitivity to these drugs, patients should undergo a" exact="complete" post="allergy workup to identify a safe alternative, considering that"/>
  <result pre="suspected hypersensitivity to these drugs, patients should undergo a complete" exact="allergy" post="workup to identify a safe alternative, considering that the"/>
  <result pre="and to Remdesivir is unknown [32]. A confident diagnosis of" exact="drug hypersensitivity" post="can be reached by performing a drug provocation test"/>
  <result pre="to Remdesivir is unknown [32]. A confident diagnosis of drug" exact="hypersensitivity" post="can be reached by performing a drug provocation test"/>
  <result pre="provocation test (DPT) with the culprit drug. Anaphylaxis or severe" exact="cutaneous" post="adverse reactions (SCARs) represent a contraindication to DPT with"/>
  <result pre="be settled down with the culprit. Both immediate and delayed" exact="hypersensitivity" post="reactions have been described for macrolides with a prevalence"/>
  <result pre="class (i.e., clarithromycin) can be safely used because of the" exact="low grade" post="of cross-reactivity after ascertaining tolerance under medical surveillance. Hydroxychloroquine"/>
  <result pre="it has been reported a prevalence of 3.9% of moderate-severe" exact="systemic" post="reactions [31]. Heparins [34], mainly low molecular weight heparins,"/>
  <result pre="treat complications of COVID-19 infection. The most common type of" exact="hypersensitivity" post="reactions to low molecular weight heparins consists of the"/>
  <result pre="patients. Baboon syndrome, DRESS (drug rash occurring with eosinophilia and" exact="systemic" post="symptoms) syndrome, AGEP (acute generalized exanthematous pustulosis), and TEN"/>
  <result pre="pustulosis), and TEN (toxic epidermal necrolysis), are very uncommon. Immediate-type" exact="hypersensitivity" post="reactions occur only sporadically. Cross-reactivity of different low molecular"/>
  <result pre="it is indicated only for children older than 2Â months." exact="Allergic" post="reactions are triggered by skin, mucous membrane (oral, conjunctiva,"/>
  <result pre="rectal, vaginal), and parenteral exposure [35]. Contact delayed reactions like" exact="dermatitis" post="can be provoked by its frequent use [35]. Moreover,"/>
  <result pre="by its frequent use [35]. Moreover, chlorhexidine can cause immediate" exact="systemic" post="reactions such as anaphylaxis [36]. Higher concentrations of chlorhexidine"/>
  <result pre="workers during the COVID-19 pandemic, an increased incidence of Chlorhexidine" exact="allergy" post="could develop. The use of low concentrations of chlorhexidine"/>
  <result pre="chlorhexidine (0.5â€&quot;2% weight/volume) is suggested to prevent sensitization. Patients with" exact="latex allergy" post="cannot use latex gloves. Caution is also advised in"/>
  <result pre="(0.5â€&quot;2% weight/volume) is suggested to prevent sensitization. Patients with latex" exact="allergy" post="cannot use latex gloves. Caution is also advised in"/>
  <result pre="in patients at risk of developing latex sensitization: children with" exact="atopic dermatitis," post="children with any other allergic disease, spina bifida patients,"/>
  <result pre="latex sensitization: children with atopic dermatitis, children with any other" exact="allergic disease," post="spina bifida patients, or other conditions with high exposure"/>
  <result pre="children with atopic dermatitis, children with any other allergic disease," exact="spina bifida" post="patients, or other conditions with high exposure to latex"/>
  <result pre="suggested as personal protective equipment during the COVID-19 epidemic. Latex" exact="hypersensitivity" post="can cause mild cutaneous or respiratory reactions to severe"/>
  <result pre="equipment during the COVID-19 epidemic. Latex hypersensitivity can cause mild" exact="cutaneous" post="or respiratory reactions to severe systemic reactions [12]. Latex"/>
  <result pre="the COVID-19 epidemic. Latex hypersensitivity can cause mild cutaneous or" exact="respiratory" post="reactions to severe systemic reactions [12]. Latex allergy prevalence"/>
  <result pre="hypersensitivity can cause mild cutaneous or respiratory reactions to severe" exact="systemic" post="reactions [12]. Latex allergy prevalence ranges from 1 to"/>
  <result pre="cutaneous or respiratory reactions to severe systemic reactions [12]. Latex" exact="allergy" post="prevalence ranges from 1 to 5% in the general"/>
  <result pre="population. Subjects at risk for latex sensitization include children with" exact="atopic dermatitis," post="children with any other allergic disease, patients with spina"/>
  <result pre="sensitization include children with atopic dermatitis, children with any other" exact="allergic disease," post="patients with spina bifida and genitourinary malformations, or other"/>
  <result pre="atopic dermatitis, children with any other allergic disease, patients with" exact="spina bifida" post="and genitourinary malformations, or other conditions with high exposure"/>
  <result pre="used since it means that the additive content is low." exact="Urticaria" post="In patients with chronic spontaneous urticaria (CSU) unresponsive to"/>
  <result pre="that the additive content is low. Urticaria In patients with" exact="chronic" post="spontaneous urticaria (CSU) unresponsive to 2nd generation H1-antihistamines, ongoing"/>
  <result pre="additive content is low. Urticaria In patients with chronic spontaneous" exact="urticaria" post="(CSU) unresponsive to 2nd generation H1-antihistamines, ongoing treatment with"/>
  <result pre="recommended as a treatment for children older than 12â€‰years with" exact="chronic" post="spontaneous urticaria (CSU) unresponsive to 2nd-generation H1-antihistamines [38]. This"/>
  <result pre="a treatment for children older than 12â€‰years with chronic spontaneous" exact="urticaria" post="(CSU) unresponsive to 2nd-generation H1-antihistamines [38]. This therapy is"/>
  <result pre="continue to use their routine treatment, including omalizumab, to prevent" exact="disease" post="exacerbations, unnecessary visits to physicians, and hospitalization [39, 40]."/>
  <result pre="(â‰¤1â€‰mg/kg/day) is suggested due to a minor increased risk of" exact="viral" post="infections, mainly respiratory tract infections [39, 41]. For patients"/>
  <result pre="due to a minor increased risk of viral infections, mainly" exact="respiratory" post="tract infections [39, 41]. For patients with a new"/>
  <result pre="a minor increased risk of viral infections, mainly respiratory tract" exact="infections" post="[39, 41]. For patients with a new CSU diagnosis"/>
  <result pre="cyclosporine, for dermatologic diseases is contraindicated in patients with active" exact="infections" post="[42]. Since available data suggest multiple cytokine axis activations"/>
  <result pre="Since available data suggest multiple cytokine axis activations in the" exact="viral" post="immune response in patients with COVID-19, broad immunosuppression may"/>
  <result pre="the potential to increase susceptibility, persistence, and reactivation of the" exact="viral infection." post="Immunosuppressive agents may decrease cytokines that recruit and differentiate"/>
  <result pre="be less involved in the previously mentioned components of the" exact="viral" post="immune response. Whether biologic agents may increase the risk"/>
  <result pre="immune response. Whether biologic agents may increase the risk of" exact="infection" post="or cause a severe disease is unknown. Rare allergic"/>
  <result pre="may increase the risk of infection or cause a severe" exact="disease" post="is unknown. Rare allergic diseases In pediatric patients, with"/>
  <result pre="Rare allergic diseases In pediatric patients, with a history of" exact="systemic" post="reactions to Hymenoptera venom not isolated to the skin,"/>
  <result pre="doses may be considered in patients in the maintenance phase." exact="Systemic" post="reactions to Hymenoptera venom could be life-threatening [44â€&quot;46]. Thus,"/>
  <result pre="be delayed or suspended. In patients with suggestive symptoms of" exact="eosinophilic esophagitis" post="(EoE), the esophagogastroduodenoscopy should not be deferred in case"/>
  <result pre="delayed or suspended. In patients with suggestive symptoms of eosinophilic" exact="esophagitis" post="(EoE), the esophagogastroduodenoscopy should not be deferred in case"/>
  <result pre="should not be deferred in case of severe dysphagia or" exact="dyspepsia" post="with alarm symptoms (i.e., weight loss). The esophagogastroduodenoscopy is"/>
  <result pre="are generally healthy except for atopic comorbidities such as asthma," exact="allergic rhinitis," post="eczema, and IgE mediated food allergy, which must be"/>
  <result pre="comorbidities such as asthma, allergic rhinitis, eczema, and IgE mediated" exact="food allergy," post="which must be maintained under control [47, 48]. Most"/>
  <result pre="food impaction that required urgent endoscopy procedures or dysphagia or" exact="dyspepsia" post="with alarm symptoms endoscopy should not be deferred. Immunization"/>
  <result pre="with alarm symptoms endoscopy should not be deferred. Immunization and" exact="immunodeficiency" post="Routine immunization activities, both for primary cycles and boosters,"/>
  <result pre="be deferred. Immunization and immunodeficiency Routine immunization activities, both for" exact="primary" post="cycles and boosters, as per National vaccine schedule recommendations,"/>
  <result pre="the Referral Center reports specific contraindications for the child with" exact="allergy" post="and/or immunodeficiency. This recommendation also applies to household members."/>
  <result pre="Health System [49, 50]. Therefore, routine immunization activities, both for" exact="primary" post="cycles and boosters, as per national vaccine schedule recommendations,"/>
  <result pre="to be maintained, unless specific contraindications for the child with" exact="allergy" post="and/or immunodeficiency exist [51]. Protection measures for children and"/>
  <result pre="maintained, unless specific contraindications for the child with allergy and/or" exact="immunodeficiency" post="exist [51]. Protection measures for children and healthcare workers"/>
  <result pre="operators. Inactivated influenza vaccine should be likewise considered in all" exact="primary" post="immunodeficiency (PID) patients unless medical contraindications exist or the"/>
  <result pre="Inactivated influenza vaccine should be likewise considered in all primary" exact="immunodeficiency" post="(PID) patients unless medical contraindications exist or the patient"/>
  <result pre="influenza vaccine should be likewise considered in all primary immunodeficiency" exact="(PID)" post="patients unless medical contraindications exist or the patient is"/>
  <result pre="also strongly recommended in household contacts of PID patients. The" exact="American" post="Academy of Pediatrics, unless specific contraindications exist, recommended routine"/>
  <result pre="in high-risk groups [52]. Clinical spectrum of COVID-19 and influenza" exact="infections" post="are very similar [53]. Nevertheless, some primary immunodeficiency (PID)"/>
  <result pre="COVID-19 and influenza infections are very similar [53]. Nevertheless, some" exact="primary" post="immunodeficiency (PID) patients, especially those with chronic lung disease,"/>
  <result pre="and influenza infections are very similar [53]. Nevertheless, some primary" exact="immunodeficiency" post="(PID) patients, especially those with chronic lung disease, might"/>
  <result pre="influenza infections are very similar [53]. Nevertheless, some primary immunodeficiency" exact="(PID)" post="patients, especially those with chronic lung disease, might have"/>
  <result pre="[53]. Nevertheless, some primary immunodeficiency (PID) patients, especially those with" exact="chronic" post="lung disease, might have a more severe clinical course"/>
  <result pre="Nevertheless, some primary immunodeficiency (PID) patients, especially those with chronic" exact="lung disease," post="might have a more severe clinical course [54]. During"/>
  <result pre="programs has also been suggested for 2020â€&quot;2021 by the Italian" exact="Pediatric" post="Society, with particular consideration for children under 6Â years"/>
  <result pre="for children under 6Â years of age and patients with" exact="chronic" post="underlying conditions [50]. The use of airborne precautions in"/>
  <result pre="patients. Immunoglobulin replacement therapy represents a life-saving treatment for many" exact="primary" post="immunodeficiencies (PIDs), including hypo/agammaglobulinemia and immunodeficiencies characterized by combined"/>
  <result pre="RNA has been detected in plasma or serum collected from" exact="symptomatic" post="COVID-19 patients but also in asymptomatic blood donors [57,"/>
  <result pre="investigation for SARS-CoV-2 is recommended after public exposure and when" exact="acute" post="respiratory or gastrointestinal symptoms occur. After exposure to SARS-CoV-2"/>
  <result pre="for SARS-CoV-2 is recommended after public exposure and when acute" exact="respiratory" post="or gastrointestinal symptoms occur. After exposure to SARS-CoV-2 in"/>
  <result pre="the immunology specialist. Some PID patients, especially those associated with" exact="chronic" post="lung disease, might be at higher risk for a"/>
  <result pre="immunology specialist. Some PID patients, especially those associated with chronic" exact="lung disease," post="might be at higher risk for a more severe"/>
  <result pre="after public exposure in severe forms of PIDs and when" exact="acute" post="respiratory or gastrointestinal symptoms occur, according to also to"/>
  <result pre="public exposure in severe forms of PIDs and when acute" exact="respiratory" post="or gastrointestinal symptoms occur, according to also to health"/>
  <result pre="[11]. It must be remembered that in some patients, the" exact="viral" post="shedding could be prolonged because of a slow clearance"/>
  <result pre="negative test results, without exposure or recent contact with subjects" exact="symptomatic" post="or virus-positive or who have not recently traveled to"/>
  <result pre="with infected people or even mild, but suggestive symptoms of" exact="viral infection" post="are present. Clinically, these results are manifested in better"/>
  <result pre="infected people or even mild, but suggestive symptoms of viral" exact="infection" post="are present. Clinically, these results are manifested in better"/>
  <result pre="Clinically, these results are manifested in better control of the" exact="allergic rhinitis" post="symptoms and, especially, in asthma prevention, which could be"/>
  <result pre="these results are manifested in better control of the allergic" exact="rhinitis" post="symptoms and, especially, in asthma prevention, which could be"/>
  <result pre="better control of the allergic rhinitis symptoms and, especially, in" exact="asthma" post="prevention, which could be confused with symptoms of viral"/>
  <result pre="in asthma prevention, which could be confused with symptoms of" exact="viral infection." post="Moreover, AIT determines a decrease in the medication use"/>
  <result pre="and inhaled therapy) that could reduce the risk of spreading" exact="viral" post="infections (like COVID-19) in other subjects and the possible"/>
  <result pre="inhaled therapy) that could reduce the risk of spreading viral" exact="infections" post="(like COVID-19) in other subjects and the possible worsening"/>
  <result pre="COVID-19) in other subjects and the possible worsening of a" exact="viral infection" post="in the patient himself. Immunotherapy (SCIT and SLIT) must"/>
  <result pre="in other subjects and the possible worsening of a viral" exact="infection" post="in the patient himself. Immunotherapy (SCIT and SLIT) must"/>
  <result pre="himself. Immunotherapy (SCIT and SLIT) must be interrupted immediately: in" exact="symptomatic" post="patients exposed to contact with COVID-19 positive individuals in"/>
  <result pre="but positive test results in patients with an accentuation of" exact="respiratory" post="symptoms related to possible virosis, even if only an"/>
  <result pre="dangerous to continue AIT in individuals with suspected or confirmed" exact="infection" post="with COVID-19 [67]. Moreover, it is useful to avoid"/>
  <result pre="the accentuation of symptoms in subjects with seasonal symptoms (allergic" exact="rhinitis" post="and/or asthma episodes), also following the administration of immunotherapy"/>
  <result pre="of symptoms in subjects with seasonal symptoms (allergic rhinitis and/or" exact="asthma" post="episodes), also following the administration of immunotherapy and possible"/>
  <result pre="episodes), also following the administration of immunotherapy and possible concomitant" exact="viral" post="infections. In this case, it would be more complex"/>
  <result pre="would be more complex to effectively distinguish the clinical manifestations," exact="viral" post="and/or allergic, often present concomitantly and which could delay"/>
  <result pre="environment The extensive use of personal protective equipment represents the" exact="primary" post="defense for allergic children during a COVID-19 pandemic. Face"/>
  <result pre="[68â€&quot;70]. The filterless FFP2 / 3 respirators represent an optimal" exact="primary" post="and bi-directional defense even against pollen, mites, and viruses."/>
  <result pre="mites, and viruses. It is essential to avoid that the" exact="rhinitis" post="symptoms related to pollinosis can be confused with the"/>
  <result pre="is essential to avoid that the rhinitis symptoms related to" exact="pollinosis" post="can be confused with the COVID-19 infection, generating situations"/>
  <result pre="affects the fit on the face and its effectiveness. Promote" exact="periodic" post="ventilation, both in domestic and indoor community environments The"/>
  <result pre="of the vehicle and industrial emissions, could promote not only" exact="respiratory" post="health but also children less vulnerable to SARS-CoV-2 [77,"/>
  <result pre="consultation and skin prick test (SPT) in children with suspect" exact="respiratory" post="allergy and/or food allergy [79]. Allergology consultation and SPT"/>
  <result pre="and skin prick test (SPT) in children with suspect respiratory" exact="allergy" post="and/or food allergy [79]. Allergology consultation and SPT in"/>
  <result pre="prick test (SPT) in children with suspect respiratory allergy and/or" exact="food allergy" post="[79]. Allergology consultation and SPT in children with the"/>
  <result pre="test (SPT) in children with suspect respiratory allergy and/or food" exact="allergy" post="[79]. Allergology consultation and SPT in children with the"/>
  <result pre="Allergology consultation and SPT in children with the specific 2019-nCoV" exact="infection" post="must not be performed. Allergology consultation and SPT in"/>
  <result pre="performed. Allergology consultation and SPT in children with suspected 2019-nCoV" exact="infection" post="(e.g., cough, rhinitis, fever, and epidemiological criteria) must not"/>
  <result pre="not be performed. If the child and/or the accompanying parentâ€™s" exact="infectious" post="status is unknown regarding 2019-nCoV, it is necessary: Space"/>
  <result pre="parentâ€™s infectious status is unknown regarding 2019-nCoV, it is necessary:" exact="Space" post="appointment to avoid contact between the previous patient and"/>
  <result pre="reduce as much as possible the risk of spreading the" exact="viral infection." post="In general, not deferrable clinical patterns requiring a fast"/>
  <result pre="infection. In general, not deferrable clinical patterns requiring a fast" exact="allergy" post="workup should include: a recent history of anaphylaxis, with"/>
  <result pre="adrenaline; the appearance of symptoms evocative of food protein-induced enterocolitis" exact="syndrome" post="(FPIES), if the culprit food is essential from a"/>
  <result pre="for the toddler, and to avoid the further appearance of" exact="acute" post="symptoms; IgE mediated food allergies, such as cowâ€™s milk"/>
  <result pre="of acute symptoms; IgE mediated food allergies, such as cowâ€™s" exact="milk allergy," post="wheat allergy, or allergies to other nutritionally essential food;"/>
  <result pre="symptoms; IgE mediated food allergies, such as cowâ€™s milk allergy," exact="wheat allergy," post="or allergies to other nutritionally essential food; suspected drug"/>
  <result pre="food allergies, such as cowâ€™s milk allergy, wheat allergy, or" exact="allergies" post="to other nutritionally essential food; suspected drug allergies, in"/>
  <result pre="need treatment with the possible culprit drug (including antibiotics in" exact="cystic fibrosis" post="patients, patients with tuberculosis or immunocompromised; vaccines in immunocompromised"/>
  <result pre="culprit drug (including antibiotics in cystic fibrosis patients, patients with" exact="tuberculosis" post="or immunocompromised; vaccines in immunocompromised children; chemotherapeutic agents in"/>
  <result pre="areas of the body are interested, or a history of" exact="cutaneous" post="infection; severe reactions to Hymenoptera venoms, which are more"/>
  <result pre="the medical staff properly equipped to reduce the risk of" exact="infection" post="for the staff, the child, and the caregiver. In"/>
  <result pre="rather than skin prick tests. Drug challenges to diagnose an" exact="allergy" post="or to confirm a hypersensitivity reaction, or to explore"/>
  <result pre="Drug challenges to diagnose an allergy or to confirm a" exact="hypersensitivity" post="reaction, or to explore possible alternatives (antibiotics, NSAIDs, perioperative"/>
  <result pre="of school activities. The effects on patients suffering from allergic" exact="respiratory" post="pathology are twofold. On the one hand, the difficulty"/>
  <result pre="On the other hand, the virus led to the sheer" exact="anxiety" post="and fears of both patients and their families. In"/>
  <result pre="to equip patients and families with practical knowledge in the" exact="absence of" post="scheduled visits. As a result, they will feel less"/>
  <result pre="will feel less alone and more prepared to deal with" exact="disease" post="management. Telemedicine may provide a fundamental contribution to maintain"/>
  <result pre="be continued regularly to keep the skin, eyes and nasal" exact="allergy" post="symptoms well controlled from allergens exposure; for subjects not"/>
  <result pre="suspicion thereof immediately upon the appearance of symptoms of COVID-19" exact="infection" post="(or potential symptoms); active and passive cigarette smoking is"/>
  <result pre="as 112. Direct access to the emergency room must be" exact="limited" post="only for extreme urgency and seriousness [81]. When schools"/>
  <result pre="that washing hands should not be excessive in children with" exact="atopic dermatitis." post="for children with a food allergy, the exclusion of"/>
  <result pre="excessive in children with atopic dermatitis. for children with a" exact="food allergy," post="the exclusion of the food in question; emergency therapy,"/>
  <result pre="asymptomatic allergic children have the right to undergo all recommended" exact="childhood" post="vaccinations. Failure to comply with the vaccination calendar can"/>
  <result pre="children have the right to undergo all recommended childhood vaccinations." exact="Failure" post="to comply with the vaccination calendar can frustrate the"/>
  <result pre="consultations and follow-up visits in patients with suspected or ascertained" exact="allergy" post="or immunodeficiency. Sharing between families and allergy or immunology"/>
  <result pre="suspected or ascertained allergy or immunodeficiency. Sharing between families and" exact="allergy" post="or immunology specialists clinical materials, such as images, investigations,"/>
  <result pre="laboratory data, may help manage many simple immune-mediated diseases like" exact="urticaria" post="or recurrent respiratory infections. Indeed, history plays a pivotal"/>
  <result pre="may help manage many simple immune-mediated diseases like urticaria or" exact="recurrent" post="respiratory infections. Indeed, history plays a pivotal role in"/>
  <result pre="help manage many simple immune-mediated diseases like urticaria or recurrent" exact="respiratory" post="infections. Indeed, history plays a pivotal role in establishing"/>
  <result pre="plays a pivotal role in establishing when parentsâ€™ perception of" exact="hypersensitivity" post="or immune-mediated symptoms fit with a defined allergic or"/>
  <result pre="hypersensitivity or immune-mediated symptoms fit with a defined allergic or" exact="immunodeficiency" post="condition or an exacerbation of a previously diagnosed immunological"/>
  <result pre="immunodeficiency condition or an exacerbation of a previously diagnosed immunological" exact="disease" post="occur. At the same time, specialists must not overlook"/>
  <result pre="establishing if a child with the suspected allergic or immune-mediated" exact="disease" post="need for an urgent hospital-based consultation, with the possible"/>
  <result pre="related laboratory or instrumental findings indicating the need for an" exact="allergy" post="or immunology specialistâ€™s need for an urgent consultation Presenting"/>
  <result pre="Presenting symptoms and/or laboratory findings More probable allergic and/or immune-mediated" exact="disease" post="Possible alternative diagnosis Uncontrolled asthma-like symptoms Severe asthma or"/>
  <result pre="allergic and/or immune-mediated disease Possible alternative diagnosis Uncontrolled asthma-like symptoms" exact="Severe" post="asthma or asthma with comorbidities (asthma plus) Dysfunctional breathing"/>
  <result pre="and/or immune-mediated disease Possible alternative diagnosis Uncontrolled asthma-like symptoms Severe" exact="asthma" post="or asthma with comorbidities (asthma plus) Dysfunctional breathing disorders,"/>
  <result pre="disease Possible alternative diagnosis Uncontrolled asthma-like symptoms Severe asthma or" exact="asthma" post="with comorbidities (asthma plus) Dysfunctional breathing disorders, aspiration disease,"/>
  <result pre="Dysfunctional breathing disorders, aspiration disease, foreign bodies ( Recent severe" exact="asthma" post="attack Uncontrolled asthma Dysfunctional breathing disorders, aspiration disease, foreign"/>
  <result pre="aspiration disease, foreign bodies ( Recent severe asthma attack Uncontrolled" exact="asthma" post="Dysfunctional breathing disorders, aspiration disease, foreign bodies ( Chronic"/>
  <result pre="Uncontrolled asthma Dysfunctional breathing disorders, aspiration disease, foreign bodies (" exact="Chronic" post="diarrhea with failure to thrive and/or malabsorption FPIES or"/>
  <result pre="asthma Dysfunctional breathing disorders, aspiration disease, foreign bodies ( Chronic" exact="diarrhea" post="with failure to thrive and/or malabsorption FPIES or eosinophilic"/>
  <result pre="Chronic diarrhea with failure to thrive and/or malabsorption FPIES or" exact="eosinophilic gastroenteritis" post="Combined immunodeficiency, cystic fibrosis, autoimmune enteritis, gastrointestinal infections Acute"/>
  <result pre="diarrhea with failure to thrive and/or malabsorption FPIES or eosinophilic" exact="gastroenteritis" post="Combined immunodeficiency, cystic fibrosis, autoimmune enteritis, gastrointestinal infections Acute"/>
  <result pre="with failure to thrive and/or malabsorption FPIES or eosinophilic gastroenteritis" exact="Combined" post="immunodeficiency, cystic fibrosis, autoimmune enteritis, gastrointestinal infections Acute hypersensitivity"/>
  <result pre="to thrive and/or malabsorption FPIES or eosinophilic gastroenteritis Combined immunodeficiency," exact="cystic fibrosis," post="autoimmune enteritis, gastrointestinal infections Acute hypersensitivity symptoms occurring after"/>
  <result pre="and/or malabsorption FPIES or eosinophilic gastroenteritis Combined immunodeficiency, cystic fibrosis," exact="autoimmune" post="enteritis, gastrointestinal infections Acute hypersensitivity symptoms occurring after the"/>
  <result pre="or eosinophilic gastroenteritis Combined immunodeficiency, cystic fibrosis, autoimmune enteritis, gastrointestinal" exact="infections" post="Acute hypersensitivity symptoms occurring after the first introduction/s of"/>
  <result pre="eosinophilic gastroenteritis Combined immunodeficiency, cystic fibrosis, autoimmune enteritis, gastrointestinal infections" exact="Acute" post="hypersensitivity symptoms occurring after the first introduction/s of a"/>
  <result pre="gastroenteritis Combined immunodeficiency, cystic fibrosis, autoimmune enteritis, gastrointestinal infections Acute" exact="hypersensitivity" post="symptoms occurring after the first introduction/s of a fooda"/>
  <result pre="after the first introduction/s of a fooda Anaphylaxis FPIES, spontaneous" exact="urticaria" post="Acute hypersensitivity symptoms occurring after drug administrationb Anaphylaxis Mastocytosis"/>
  <result pre="the first introduction/s of a fooda Anaphylaxis FPIES, spontaneous urticaria" exact="Acute" post="hypersensitivity symptoms occurring after drug administrationb Anaphylaxis Mastocytosis or"/>
  <result pre="first introduction/s of a fooda Anaphylaxis FPIES, spontaneous urticaria Acute" exact="hypersensitivity" post="symptoms occurring after drug administrationb Anaphylaxis Mastocytosis or idiopathic"/>
  <result pre="administrationb Anaphylaxis Mastocytosis or idiopathic mast cell activation syndrome, spontaneous" exact="urticaria" post="Severe cutaneous adverse reaction (SCAR) w/wt systemic symptoms occurring"/>
  <result pre="Anaphylaxis Mastocytosis or idiopathic mast cell activation syndrome, spontaneous urticaria" exact="Severe" post="cutaneous adverse reaction (SCAR) w/wt systemic symptoms occurring after"/>
  <result pre="Mastocytosis or idiopathic mast cell activation syndrome, spontaneous urticaria Severe" exact="cutaneous" post="adverse reaction (SCAR) w/wt systemic symptoms occurring after drug"/>
  <result pre="activation syndrome, spontaneous urticaria Severe cutaneous adverse reaction (SCAR) w/wt" exact="systemic" post="symptoms occurring after drug administrationb DRESS, TEN, Stevens-Johnson syndrome"/>
  <result pre="(SCAR) w/wt systemic symptoms occurring after drug administrationb DRESS, TEN," exact="Stevens-Johnson syndrome" post="viral infection (EBV, CMV, HHSV6, others), staphylococcal and streptococcal"/>
  <result pre="w/wt systemic symptoms occurring after drug administrationb DRESS, TEN, Stevens-Johnson" exact="syndrome" post="viral infection (EBV, CMV, HHSV6, others), staphylococcal and streptococcal"/>
  <result pre="systemic symptoms occurring after drug administrationb DRESS, TEN, Stevens-Johnson syndrome" exact="viral infection" post="(EBV, CMV, HHSV6, others), staphylococcal and streptococcal shock syndrome,"/>
  <result pre="symptoms occurring after drug administrationb DRESS, TEN, Stevens-Johnson syndrome viral" exact="infection" post="(EBV, CMV, HHSV6, others), staphylococcal and streptococcal shock syndrome,"/>
  <result pre="infection (EBV, CMV, HHSV6, others), staphylococcal and streptococcal shock syndrome," exact="autoimmune diseases" post="Acute hypersensitivity symptoms occurring after vaccine administration c Anaphylaxis"/>
  <result pre="CMV, HHSV6, others), staphylococcal and streptococcal shock syndrome, autoimmune diseases" exact="Acute" post="hypersensitivity symptoms occurring after vaccine administration c Anaphylaxis (rare)"/>
  <result pre="HHSV6, others), staphylococcal and streptococcal shock syndrome, autoimmune diseases Acute" exact="hypersensitivity" post="symptoms occurring after vaccine administration c Anaphylaxis (rare) Spontaneous"/>
  <result pre="Acute hypersensitivity symptoms occurring after vaccine administration c Anaphylaxis (rare)" exact="Spontaneous" post="urticaria Chronic unexplained cough Wet: protracted bacterial bronchitis, bronchiectasis"/>
  <result pre="hypersensitivity symptoms occurring after vaccine administration c Anaphylaxis (rare) Spontaneous" exact="urticaria" post="Chronic unexplained cough Wet: protracted bacterial bronchitis, bronchiectasis Dry"/>
  <result pre="symptoms occurring after vaccine administration c Anaphylaxis (rare) Spontaneous urticaria" exact="Chronic" post="unexplained cough Wet: protracted bacterial bronchitis, bronchiectasis Dry or"/>
  <result pre="c Anaphylaxis (rare) Spontaneous urticaria Chronic unexplained cough Wet: protracted" exact="bacterial" post="bronchitis, bronchiectasis Dry or mixed: foreign body, pertussis or"/>
  <result pre="(rare) Spontaneous urticaria Chronic unexplained cough Wet: protracted bacterial bronchitis," exact="bronchiectasis" post="Dry or mixed: foreign body, pertussis or parapertussis, or"/>
  <result pre="Wet: protracted bacterial bronchitis, bronchiectasis Dry or mixed: foreign body," exact="pertussis" post="or parapertussis, or Mycoplasma infection Pulmonary tuberculosis, tracheobronchomalacia, vascular"/>
  <result pre="Dry or mixed: foreign body, pertussis or parapertussis, or Mycoplasma" exact="infection" post="Pulmonary tuberculosis, tracheobronchomalacia, vascular rings/slings, aspiration syndrome, cystic fibrosis,"/>
  <result pre="or mixed: foreign body, pertussis or parapertussis, or Mycoplasma infection" exact="Pulmonary" post="tuberculosis, tracheobronchomalacia, vascular rings/slings, aspiration syndrome, cystic fibrosis, primary"/>
  <result pre="body, pertussis or parapertussis, or Mycoplasma infection Pulmonary tuberculosis, tracheobronchomalacia," exact="vascular" post="rings/slings, aspiration syndrome, cystic fibrosis, primary ciliary dyskinesia Prolonged"/>
  <result pre="or Mycoplasma infection Pulmonary tuberculosis, tracheobronchomalacia, vascular rings/slings, aspiration syndrome," exact="cystic fibrosis," post="primary ciliary dyskinesia Prolonged respiratory symptoms and/or interstitial pneumonia,"/>
  <result pre="infection Pulmonary tuberculosis, tracheobronchomalacia, vascular rings/slings, aspiration syndrome, cystic fibrosis," exact="primary" post="ciliary dyskinesia Prolonged respiratory symptoms and/or interstitial pneumonia, especially"/>
  <result pre="vascular rings/slings, aspiration syndrome, cystic fibrosis, primary ciliary dyskinesia Prolonged" exact="respiratory" post="symptoms and/or interstitial pneumonia, especially if combined with poor"/>
  <result pre="and/or interstitial pneumonia, especially if combined with poor weight gain" exact="Combined" post="immunodeficiency interstitial lung disease, cystic fibrosis, Shwachman disease Hypereosinophilia"/>
  <result pre="interstitial pneumonia, especially if combined with poor weight gain Combined" exact="immunodeficiency" post="interstitial lung disease, cystic fibrosis, Shwachman disease Hypereosinophilia (not"/>
  <result pre="pneumonia, especially if combined with poor weight gain Combined immunodeficiency" exact="interstitial lung disease," post="cystic fibrosis, Shwachman disease Hypereosinophilia (not allergy-related) Hypereosinophilic syndromes,"/>
  <result pre="especially if combined with poor weight gain Combined immunodeficiency interstitial" exact="lung disease," post="cystic fibrosis, Shwachman disease Hypereosinophilia (not allergy-related) Hypereosinophilic syndromes,"/>
  <result pre="combined with poor weight gain Combined immunodeficiency interstitial lung disease," exact="cystic fibrosis," post="Shwachman disease Hypereosinophilia (not allergy-related) Hypereosinophilic syndromes, parasitic disease"/>
  <result pre="weight gain Combined immunodeficiency interstitial lung disease, cystic fibrosis, Shwachman" exact="disease" post="Hypereosinophilia (not allergy-related) Hypereosinophilic syndromes, parasitic disease Malignancies, primary"/>
  <result pre="cystic fibrosis, Shwachman disease Hypereosinophilia (not allergy-related) Hypereosinophilic syndromes, parasitic" exact="disease" post="Malignancies, primary atopic disorder Severe neutropenia (9/L) in the"/>
  <result pre="Shwachman disease Hypereosinophilia (not allergy-related) Hypereosinophilic syndromes, parasitic disease Malignancies," exact="primary" post="atopic disorder Severe neutropenia (9/L) in the context of"/>
  <result pre="(not allergy-related) Hypereosinophilic syndromes, parasitic disease Malignancies, primary atopic disorder" exact="Severe" post="neutropenia (9/L) in the context of a pyogenic infection"/>
  <result pre="allergy-related) Hypereosinophilic syndromes, parasitic disease Malignancies, primary atopic disorder Severe" exact="neutropenia" post="(9/L) in the context of a pyogenic infection Severe"/>
  <result pre="disorder Severe neutropenia (9/L) in the context of a pyogenic" exact="infection" post="Severe congenital neutropenia (SCN) Drug-related agranulocytosis, aplastic anemia, autoimmune"/>
  <result pre="Severe neutropenia (9/L) in the context of a pyogenic infection" exact="Severe" post="congenital neutropenia (SCN) Drug-related agranulocytosis, aplastic anemia, autoimmune neutropenia"/>
  <result pre="neutropenia (9/L) in the context of a pyogenic infection Severe" exact="congenital" post="neutropenia (SCN) Drug-related agranulocytosis, aplastic anemia, autoimmune neutropenia (rare)"/>
  <result pre="(9/L) in the context of a pyogenic infection Severe congenital" exact="neutropenia" post="(SCN) Drug-related agranulocytosis, aplastic anemia, autoimmune neutropenia (rare) Severe"/>
  <result pre="of a pyogenic infection Severe congenital neutropenia (SCN) Drug-related agranulocytosis," exact="aplastic anemia," post="autoimmune neutropenia (rare) Severe lymphopenia in the context of"/>
  <result pre="pyogenic infection Severe congenital neutropenia (SCN) Drug-related agranulocytosis, aplastic anemia," exact="autoimmune" post="neutropenia (rare) Severe lymphopenia in the context of severe"/>
  <result pre="infection Severe congenital neutropenia (SCN) Drug-related agranulocytosis, aplastic anemia, autoimmune" exact="neutropenia" post="(rare) Severe lymphopenia in the context of severe or"/>
  <result pre="congenital neutropenia (SCN) Drug-related agranulocytosis, aplastic anemia, autoimmune neutropenia (rare)" exact="Severe" post="lymphopenia in the context of severe or atypical infections"/>
  <result pre="neutropenia (SCN) Drug-related agranulocytosis, aplastic anemia, autoimmune neutropenia (rare) Severe" exact="lymphopenia" post="in the context of severe or atypical infections and/or"/>
  <result pre="neutropenia (rare) Severe lymphopenia in the context of severe or" exact="atypical" post="infections and/or failure to thrive Severe combined immunodeficiency (SCID)"/>
  <result pre="(rare) Severe lymphopenia in the context of severe or atypical" exact="infections" post="and/or failure to thrive Severe combined immunodeficiency (SCID) Other"/>
  <result pre="context of severe or atypical infections and/or failure to thrive" exact="Severe combined immunodeficiency" post="(SCID) Other primary immunodeficiencies Recurrent fever in a â€œsickâ€�"/>
  <result pre="of severe or atypical infections and/or failure to thrive Severe" exact="combined immunodeficiency" post="(SCID) Other primary immunodeficiencies Recurrent fever in a â€œsickâ€�"/>
  <result pre="severe or atypical infections and/or failure to thrive Severe combined" exact="immunodeficiency" post="(SCID) Other primary immunodeficiencies Recurrent fever in a â€œsickâ€�"/>
  <result pre="infections and/or failure to thrive Severe combined immunodeficiency (SCID) Other" exact="primary" post="immunodeficiencies Recurrent fever in a â€œsickâ€� appearing child Autoinflammatory"/>
  <result pre="failure to thrive Severe combined immunodeficiency (SCID) Other primary immunodeficiencies" exact="Recurrent" post="fever in a â€œsickâ€� appearing child Autoinflammatory disease Malignancies,"/>
  <result pre="primary immunodeficiencies Recurrent fever in a â€œsickâ€� appearing child Autoinflammatory" exact="disease" post="Malignancies, chronic inflammatory bowel disease, recurrent organ infections in"/>
  <result pre="Recurrent fever in a â€œsickâ€� appearing child Autoinflammatory disease Malignancies," exact="chronic" post="inflammatory bowel disease, recurrent organ infections in an immunocompromised"/>
  <result pre="fever in a â€œsickâ€� appearing child Autoinflammatory disease Malignancies, chronic" exact="inflammatory bowel disease," post="recurrent organ infections in an immunocompromised child Multiple autoimmune"/>
  <result pre="in a â€œsickâ€� appearing child Autoinflammatory disease Malignancies, chronic inflammatory" exact="bowel" post="disease, recurrent organ infections in an immunocompromised child Multiple"/>
  <result pre="â€œsickâ€� appearing child Autoinflammatory disease Malignancies, chronic inflammatory bowel disease," exact="recurrent" post="organ infections in an immunocompromised child Multiple autoimmune diseases"/>
  <result pre="child Autoinflammatory disease Malignancies, chronic inflammatory bowel disease, recurrent organ" exact="infections" post="in an immunocompromised child Multiple autoimmune diseases Primary immunodeficiencies,"/>
  <result pre="inflammatory bowel disease, recurrent organ infections in an immunocompromised child" exact="Multiple" post="autoimmune diseases Primary immunodeficiencies, systemic rheumatological disease athe condition"/>
  <result pre="bowel disease, recurrent organ infections in an immunocompromised child Multiple" exact="autoimmune diseases" post="Primary immunodeficiencies, systemic rheumatological disease athe condition needs urgent"/>
  <result pre="recurrent organ infections in an immunocompromised child Multiple autoimmune diseases" exact="Primary" post="immunodeficiencies, systemic rheumatological disease athe condition needs urgent consultation"/>
  <result pre="infections in an immunocompromised child Multiple autoimmune diseases Primary immunodeficiencies," exact="systemic" post="rheumatological disease athe condition needs urgent consultation if the"/>
  <result pre="an immunocompromised child Multiple autoimmune diseases Primary immunodeficiencies, systemic rheumatological" exact="disease" post="athe condition needs urgent consultation if the suspected food"/>
  <result pre="drug is not replaceable in a specific clinical condition (e.g.," exact="cystic fibrosis," post="neoplasms) c the condition needs urgent consultation if primary"/>
  <result pre="cystic fibrosis, neoplasms) c the condition needs urgent consultation if" exact="primary" post="series vaccination are interrupted Conclusions A recent meta-analysis investigated"/>
  <result pre="the impact of COVID-19 on the pediatric population [85]. A" exact="total" post="of 815 articles were identified. Eighteen studies with 1065"/>
  <result pre="and 553 were aged 10 to 19â€‰years) with confirmed SARS-CoV-2" exact="infection" post="were included in the final analysis. All articles reflected"/>
  <result pre="Children at any age were mostly reported to have mild" exact="respiratory" post="symptoms, namely fever, dry cough, and fatigue, or were"/>
  <result pre="Another study reported that adolescents were influenced by COVID-19 concerning" exact="emotional" post="aspects [87]. Therefore, COVID-19 seems to affect childhood and"/>
  <result pre="COVID-19 concerning emotional aspects [87]. Therefore, COVID-19 seems to affect" exact="childhood" post="and adolescence scarcely, as very recently demonstrated in Italy"/>
  <result pre="extensive debate and appropriate measures should be considered. Abbreviations SARS-COV-2" exact="Severe" post="acute respiratory syndrome â€&quot; coronavirus COVID-19 Coronavirus disease 2019"/>
  <result pre="debate and appropriate measures should be considered. Abbreviations SARS-COV-2 Severe" exact="acute" post="respiratory syndrome â€&quot; coronavirus COVID-19 Coronavirus disease 2019 SIAIP"/>
  <result pre="and appropriate measures should be considered. Abbreviations SARS-COV-2 Severe acute" exact="respiratory" post="syndrome â€&quot; coronavirus COVID-19 Coronavirus disease 2019 SIAIP SocietÃ"/>
  <result pre="appropriate measures should be considered. Abbreviations SARS-COV-2 Severe acute respiratory" exact="syndrome" post="â€&quot; coronavirus COVID-19 Coronavirus disease 2019 SIAIP SocietÃ Italiana"/>
  <result pre="Abbreviations SARS-COV-2 Severe acute respiratory syndrome â€&quot; coronavirus COVID-19 Coronavirus" exact="disease" post="2019 SIAIP SocietÃ Italiana di Allergologia ed. Immunologia Pediatrica"/>
  <result pre="Personal protective equipment ACE2 Angiotensine converting enzyme 2 FA Food" exact="allergy" post="OFC Oral food challenge OIT Oral immunotherapy WHO World"/>
  <result pre="food challenge OIT Oral immunotherapy WHO World Health Organization AD" exact="Atopic dermatitis" post="NICE National Institute for Health and Care Excellence DPT"/>
  <result pre="challenge OIT Oral immunotherapy WHO World Health Organization AD Atopic" exact="dermatitis" post="NICE National Institute for Health and Care Excellence DPT"/>
  <result pre="for Health and Care Excellence DPT Drug provocation test SCAR" exact="Severe" post="cutaneous adverse reactions CSU Chronic spontaneous urticaria VIT Venom"/>
  <result pre="Health and Care Excellence DPT Drug provocation test SCAR Severe" exact="cutaneous" post="adverse reactions CSU Chronic spontaneous urticaria VIT Venom immunotherapy"/>
  <result pre="DPT Drug provocation test SCAR Severe cutaneous adverse reactions CSU" exact="Chronic" post="spontaneous urticaria VIT Venom immunotherapy PID Primary immunodeficiencies SLIT"/>
  <result pre="provocation test SCAR Severe cutaneous adverse reactions CSU Chronic spontaneous" exact="urticaria" post="VIT Venom immunotherapy PID Primary immunodeficiencies SLIT Sublingual immunotherapy"/>
  <result pre="adverse reactions CSU Chronic spontaneous urticaria VIT Venom immunotherapy PID" exact="Primary" post="immunodeficiencies SLIT Sublingual immunotherapy SCIT Subcutaneous immunotherapy PM Particulate"/>
  <result pre="The publication has been supported by the Italian Society of" exact="Pediatric" post="Allergy and Immunology (SIAIP). Availability of data and materials"/>
  <result pre="J, Akdis C, Jutel M, et al. Intranasal corticosteroids in" exact="allergic rhinitis" post="in COVID-19 infected patients: an ARIA-EAACI statement. Allergy. 2020;"/>
  <result pre="Akdis C, Jutel M, et al. Intranasal corticosteroids in allergic" exact="rhinitis" post="in COVID-19 infected patients: an ARIA-EAACI statement. Allergy. 2020;"/>
  <result pre="Hsieh EWY, et al. COVID-19: Pandemic contingency planning for the" exact="allergy" post="and immunology clinic. J Allergy Clin Immunol Pract. 2020;"/>
  <result pre="press). 5.CiprandiGCosentinoCMilaneseMMondinoCCanonicaGWFexofenadine treatment reduces nasal congestion in allergic rhinitisAllergy2001561068107010.1034/j.1398-9995.2001.00191.x11703220 6.Managing" exact="childhood" post="allergies and immunodeficiencies during respiratory virus epidemics â€&quot; the"/>
  <result pre="5.CiprandiGCosentinoCMilaneseMMondinoCCanonicaGWFexofenadine treatment reduces nasal congestion in allergic rhinitisAllergy2001561068107010.1034/j.1398-9995.2001.00191.x11703220 6.Managing childhood" exact="allergies" post="and immunodeficiencies during respiratory virus epidemics â€&quot; the 2020"/>
  <result pre="congestion in allergic rhinitisAllergy2001561068107010.1034/j.1398-9995.2001.00191.x11703220 6.Managing childhood allergies and immunodeficiencies during" exact="respiratory" post="virus epidemics â€&quot; the 2020 COVID-19 pandemic a statement"/>
  <result pre="EAACI-section on pediatrics. PAI. 2020; (in press). 7.Global strategy for" exact="asthma" post="management and prevention (GINA). Updated 2020. www.ginasthma.com. 8.NICE 2020."/>
  <result pre="Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus" exact="Disease" post="2019 in China. N Eng J Med. 2020; (in"/>
  <result pre="population? FEBS J. First published: 2020. (in press). 14.MuraroAWerfelTHoffmann-SommergruberKRobertsGBeyerKBindslev-JensenCet al.EAACI" exact="food allergy" post="and anaphylaxis guidelines. Diagnosis and management of food allergyAllergy2014691008102510.1111/all.1242924909706"/>
  <result pre="FEBS J. First published: 2020. (in press). 14.MuraroAWerfelTHoffmann-SommergruberKRobertsGBeyerKBindslev-JensenCet al.EAACI food" exact="allergy" post="and anaphylaxis guidelines. Diagnosis and management of food allergyAllergy2014691008102510.1111/all.1242924909706"/>
  <result pre="the immune system-working in harmony to reduce the risk of" exact="infection" post="16.MartineauARJoliffeDAGreenbergLAloiaJFBergmanPDubnov-RazGet al.Vitamin D supplementation to prevent acute respiratory infections:"/>
  <result pre="the risk of infection 16.MartineauARJoliffeDAGreenbergLAloiaJFBergmanPDubnov-RazGet al.Vitamin D supplementation to prevent" exact="acute" post="respiratory infections: individual participant data meta-analysisHealth Technol Assess20192314410.3310/hta23020 17.VorilhonPArpajouBVaillant"/>
  <result pre="risk of infection 16.MartineauARJoliffeDAGreenbergLAloiaJFBergmanPDubnov-RazGet al.Vitamin D supplementation to prevent acute" exact="respiratory" post="infections: individual participant data meta-analysisHealth Technol Assess20192314410.3310/hta23020 17.VorilhonPArpajouBVaillant RousselHMerlinEPereiraBCabaillotAEfficacy"/>
  <result pre="RousselHMerlinEPereiraBCabaillotAEfficacy of vitamin C for the prevention and treatment of" exact="upper respiratory tract infection." post="A meta-analysis in childrenEur J Clin Pharmacol20197530331110.1007/s00228-018-2601-730465062 18.Calvani M,"/>
  <result pre="of vitamin C for the prevention and treatment of upper" exact="respiratory" post="tract infection. A meta-analysis in childrenEur J Clin Pharmacol20197530331110.1007/s00228-018-2601-730465062"/>
  <result pre="COVID-19 pandemic. J Am Acad Dermatol. 2020; (in press). 21.Magdaleno-TapialJMartÃ­nez-DomÃ©nechAValenzuela-OÃ±ateCFerrer-GuillÃ©nBEsteve-MartÃ­nezAZaragoza-NinetVAllergic" exact="contact dermatitis" post="to chlorhexidine in pediatric patientsPediatr Dermatol20193654054110.1111/pde.1380830838689 22.Stone TE, Kunaviktikul"/>
  <result pre="pandemic. J Am Acad Dermatol. 2020; (in press). 21.Magdaleno-TapialJMartÃ­nez-DomÃ©nechAValenzuela-OÃ±ateCFerrer-GuillÃ©nBEsteve-MartÃ­nezAZaragoza-NinetVAllergic contact" exact="dermatitis" post="to chlorhexidine in pediatric patientsPediatr Dermatol20193654054110.1111/pde.1380830838689 22.Stone TE, Kunaviktikul"/>
  <result pre="2020; (in press). 23.BukalasaJSBrunekreefBKoppelmanGHVonkJMGehringUUse of cleaning agents at home and" exact="respiratory" post="and allergic symptoms in adolescents PIAMA birth cohort studyEnviron"/>
  <result pre="Thyssen JP, Bieber T, et al. European task force on" exact="atopic dermatitis" post="statement on SARS-Cov-2 infection and atopic dermatitis. J Eur"/>
  <result pre="JP, Bieber T, et al. European task force on atopic" exact="dermatitis" post="statement on SARS-Cov-2 infection and atopic dermatitis. J Eur"/>
  <result pre="al. European task force on atopic dermatitis statement on SARS-Cov-2" exact="infection" post="and atopic dermatitis. J Eur Acad Dermatol Venereol. 2020;"/>
  <result pre="task force on atopic dermatitis statement on SARS-Cov-2 infection and" exact="atopic dermatitis." post="J Eur Acad Dermatol Venereol. 2020; (in press). 25.Zheng"/>
  <result pre="https://eczema.org/blog/advice-on-coronavirus-covid-19-for-people-with-eczema. Accessed 19 Apr 2020. 28.Torres T, Puig L. Managing" exact="cutaneous" post="immune-mediated diseases during the COVID-19 pandemic. Am J Clin"/>
  <result pre="and non-steroidal anti-inflammatory drugs in childrenItal J Pediatr201844114710.1186/s13052-018-0589-330526636 31.SoyerODemirSBilginerYBatuEDSonmezHEArÄ±cÄ±ZSet al.Severe" exact="hypersensitivity" post="reactions to biological drugs in children with rheumatic diseasesPediatr"/>
  <result pre="31.SoyerODemirSBilginerYBatuEDSonmezHEArÄ±cÄ±ZSet al.Severe hypersensitivity reactions to biological drugs in children with" exact="rheumatic" post="diseasesPediatr Allergy Immunol20193083384010.1111/pai.1311431419311 32.Grein J, Ohmagari N, Shin D,"/>
  <result pre="34.Gonzalez-DelgadoPFernandezJHypersensitivity reactions to heparinsCurr Opin Allergy Clin Immunol20161631532210.1097/ACI.000000000000028127285488 35.VuMRajgopal BalaHCahillJToholkaRNixonRImmediate" exact="hypersensitivity" post="to chlorhexidineAustralas J Dermatol201859555610.1111/ajd.1267428589697 36.ChiewchalermsriCSompornrattanaphanMWongsaCThongngarmTChlorhexidine allergy: current challenges and"/>
  <result pre="to chlorhexidineAustralas J Dermatol201859555610.1111/ajd.1267428589697 36.ChiewchalermsriCSompornrattanaphanMWongsaCThongngarmTChlorhexidine allergy: current challenges and prospectsJ" exact="Asthma" post="Allergy20201312713310.2147/JAA.S20798032210588 37.KellyKJSussmanGLatex allergy: where are we now, and how"/>
  <result pre="40.collab: British Association of Dermatologists COVID-19Omalizumab guidance. Guidance for managing" exact="urticaria" post="patients on omalizumab during the coronavirus pandemic2020 41.Wang C,"/>
  <result pre="and the use of immunomodulatory and biologic agents for severe" exact="cutaneous" post="disease: an Australia/New Zealand consensus statement. Australas J Dermatol."/>
  <result pre="epidemicAsian Pac J Allergy Immunol2020381932105090 44.BilÃ²MPravettoniVBignardiDBonadonnaPMauroMNovembreEet al.Hymenoptera venom allergy: Management" exact="of Children" post="and Adults in clinical practiceJ Investig Allergol Clin Immunol20192918020510.18176/jiaci.0310"/>
  <result pre="45.GoldenDBDemainJFreemanTGraftDTankersleyMTracyJet al.Stinging insect hypersensitivity: a practice parameter update 2016Ann Allergy" exact="Asthma" post="Immunol2017118285410.1016/j.anai.2016.10.03128007086 46.GralnekIMHassanCBeilenhoffUAntonelliGEbigdoAPellisÃ¨Met al.ESGE and ESGENA position statement on gastrointestinal"/>
  <result pre="pediatric gastroenterologist journal of pediatric gastroenterology and nutrition2020 48.Munoz-PersyMLucendoAJTreatment of" exact="eosinophilic esophagitis" post="in the pediatric patient: an evidence-based approachEur J Pediatr201817764966310.1007/s00431-018-3129-729549437"/>
  <result pre="gastroenterologist journal of pediatric gastroenterology and nutrition2020 48.Munoz-PersyMLucendoAJTreatment of eosinophilic" exact="esophagitis" post="in the pediatric patient: an evidence-based approachEur J Pediatr201817764966310.1007/s00431-018-3129-729549437"/>
  <result pre="May 2020. 50.MartireBAzzariCBadolatoRCanessaCCirilloEGalloVet al.Vaccination in immunocompromised host: recommendations of Italian" exact="primary" post="immunodeficiency network centers (IPINET)Vaccine201836243541355410.1016/j.vaccine.2018.01.06129426658 51.BonillaFAUpdate: vaccines in primary immunodeficiencyJ"/>
  <result pre="2020. 50.MartireBAzzariCBadolatoRCanessaCCirilloEGalloVet al.Vaccination in immunocompromised host: recommendations of Italian primary" exact="immunodeficiency" post="network centers (IPINET)Vaccine201836243541355410.1016/j.vaccine.2018.01.06129426658 51.BonillaFAUpdate: vaccines in primary immunodeficiencyJ Allergy"/>
  <result pre="of Italian primary immunodeficiency network centers (IPINET)Vaccine201836243541355410.1016/j.vaccine.2018.01.06129426658 51.BonillaFAUpdate: vaccines in" exact="primary" post="immunodeficiencyJ Allergy Clin Immunol201814147448110.1016/j.jaci.2017.12.98029288077 52.Committee on infectious diseases. Recommendations"/>
  <result pre="51.BonillaFAUpdate: vaccines in primary immunodeficiencyJ Allergy Clin Immunol201814147448110.1016/j.jaci.2017.12.98029288077 52.Committee on" exact="infectious diseases." post="Recommendations for prevention and control of influenza in children,"/>
  <result pre="2019;144:e20192478. 53.Lu X, Zhang L, Du H, et al. SARS-CoV-2" exact="infection" post="in children. N Engl J Med. 2020. 54.https://ipopi.org/wp-content/uploads/2020/04/COVID19_Joint_StatementUpdate2_ 20200408_"/>
  <result pre="2020. 55.BonillaFAKhanDABallasZKChinenJFrankMMHsuJTKellerMet al.Practice parameter for the diagnosis and management of" exact="primary" post="immunodeficiencyJ Allergy Clin Immunol20151361186205.e1â€&quot;7810.1016/j.jaci.2015.04.04926371839 56.Chang L, Zhao L, Gong"/>
  <result pre="56.Chang L, Zhao L, Gong H, Wang L, Wang L." exact="Severe" post="acute respiratory syndrome coronavirus 2 RNA detected in blood"/>
  <result pre="L, Zhao L, Gong H, Wang L, Wang L. Severe" exact="acute" post="respiratory syndrome coronavirus 2 RNA detected in blood donations."/>
  <result pre="Zhao L, Gong H, Wang L, Wang L. Severe acute" exact="respiratory" post="syndrome coronavirus 2 RNA detected in blood donations. Emerg"/>
  <result pre="L, Gong H, Wang L, Wang L. Severe acute respiratory" exact="syndrome" post="coronavirus 2 RNA detected in blood donations. Emerg Infect"/>
  <result pre="Infect Dis. 2020;26(7). 57.Chang L, Yan Y, Wang L. Coronavirus" exact="disease" post="2019: coronaviruses and blood safety. Transf Med Rev. 2020;"/>
  <result pre="62.WHO. Rational use of personal protective equipment (PPE) for coronavirus" exact="disease" post="(COVID-19). Interim guidance 19 2020 March 19. 63.Henderson LA,"/>
  <result pre="al. On the alert for cytokine storm: immunopathology in COVID-19." exact="Arthritis" post="Rheumatol. 2020; (in press). 64.Quinti I, Lougaris V, Milito"/>
  <result pre="role for B cells in COVID-19? Lesson from patients with" exact="agammaglobulinemia" post="[published online ahead of print, 2020 April 22]. J"/>
  <result pre="M, Paolillo C, Baresi G, FocÃ E, et al. Two" exact="X-linked agammaglobulinemia" post="patients develop pneumonia as COVID-19 manifestation but recover [published"/>
  <result pre="Paolillo C, Baresi G, FocÃ E, et al. Two X-linked" exact="agammaglobulinemia" post="patients develop pneumonia as COVID-19 manifestation but recover [published"/>
  <result pre="G, FocÃ E, et al. Two X-linked agammaglobulinemia patients develop" exact="pneumonia" post="as COVID-19 manifestation but recover [published online ahead of"/>
  <result pre="COVID-19: implications for prevention, diagnosis, and public health measures Pediatr" exact="allergy" post="Immunol2020 67.Klimek L, Jutel M, Akdis C, Bousquet J,"/>
  <result pre="pandemic: an ARIA-EAACI statement. Allergy. 2020; (in press). 68.collab: WHOCoronavirus" exact="disease" post="(COVID-19) advice for the public: when and how to"/>
  <result pre="of indoor environments in relation to the transmission of SARS-CoV-2" exact="virus infection." post="www.epicentro.it. 74.collab: World Health OrganizationAmbient Air Pollution: A Global"/>
  <result pre="exposure to air pollution and COVID-19 infection: evidence from ChinaSci" exact="Total" post="Environ202072713870410.1016/j.scitotenv.2020.13870432315904 77.ContiniDCostabileFDoes air pollution influence COVID-19 outbreaks?Atmosphere20201137710.3390/atmos11040377 78.collab: World"/>
  <result pre="of Exposure and Burden of Disease2016GenevaWorld Health Organization1121 79.Q&amp;amp;A on" exact="infection" post="prevention and control for health care workers caring for"/>
  <result pre="Sediva A, Untersmayr E, Munblit D, et al. - Managing" exact="childhood" post="allergies and immunodeficiencies during respiratory virus epidemics - the"/>
  <result pre="A, Untersmayr E, Munblit D, et al. - Managing childhood" exact="allergies" post="and immunodeficiencies during respiratory virus epidemics - the 2020"/>
  <result pre="D, et al. - Managing childhood allergies and immunodeficiencies during" exact="respiratory" post="virus epidemics - the 2020 COVID-19 pandemic. Pediatr Allergy"/>
  <result pre="survey of school's preparedness for managing anaphylaxis in pupils with" exact="food allergy." post="Eur J Pediatr. 2020; (in press). 83.NilssonLIVaccination and allergy:"/>
  <result pre="(in press). 85.Castagnoli R, Votto M, Licari A, et al." exact="Severe" post="acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children"/>
  <result pre="press). 85.Castagnoli R, Votto M, Licari A, et al. Severe" exact="acute" post="respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children and"/>
  <result pre="85.Castagnoli R, Votto M, Licari A, et al. Severe acute" exact="respiratory" post="syndrome coronavirus 2 (SARS-CoV-2) infection in children and adolescents:"/>
  <result pre="R, Votto M, Licari A, et al. Severe acute respiratory" exact="syndrome" post="coronavirus 2 (SARS-CoV-2) infection in children and adolescents: a"/>
  <result pre="A, et al. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)" exact="infection" post="in children and adolescents: a systematic review. JAMA Pediatr."/>
  <result pre="tertiary referral Hospital in Northern Italy: preliminary clinical data. Ped" exact="Infectious" post="Dis J. 2020; (in press). 87.Buzzi C, Tucci M,"/>
  <result pre="behaviors. Ital J Pediatr. 2020; (in press). 88.LicariAVottoMCastagnoliRPiccottiEOlceseRToscaMAet al.Allergy and" exact="asthma" post="in children and adolescents during the COVID outbreak: what"/>
  <result pre="COVID outbreak: what we know and how we could prevent" exact="allergy" post="and asthma flares? Allergy2020"/>
  <result pre="what we know and how we could prevent allergy and" exact="asthma" post="flares? Allergy2020"/>
 </snippets>
</snippetsTree>
